Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Ohman

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Journal of Electrocardiology|January 1, 1992
Myocardial salvage after reperfusion. Observations from analysis of serial electrocardiographic and biochemical indicesE M Ohman, R Christenson, P Clemmensen, et al.
The American Journal of Cardiology|May 4, 2000
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trendsK R Campbell, E M Ohman, W Cantor, et al.
American Journal of Clinical Pathology|September 1, 1993
Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal functionR T Vollmer, R H Christenson, K Reimer, et al.
Journal of the Royal Society of Medicine|July 1, 1987
Adrenal suppression following low-dose topical clobetasol propionateE M Ohman, S Rogers, F O Meenan, et al.
Journal of Cardiovascular Pharmacology|December 1, 1987
Beta-adrenoceptor adaptation to endurance trainingE M Ohman, J Butler, J Kelly, et al.
Coronary Artery Disease|May 1, 1994
The role of angioplasty after successful thrombolysis for acute myocardial infarctionM Labinaz, S G Ellis, H R Phillips, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarctionM P Hudson, A B Greenbaum, R A Harrington, et al.
American Heart Journal|October 20, 1998
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findingsN S Kleiman, A M Lincoff, E M Ohman, et al.
Cardiovascular Toxicology|September 6, 2002
Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapiesR H Christenson, S H Duh, M T Roe, et al.
Clinical Chemistry|September 1, 1995
Biochemical markers in suspected acute myocardial infarction: the need for early assessmentL K Newby, W B Gibler, E M Ohman, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Journal of Electrocardiology|January 1, 1992
Myocardial salvage after reperfusion. Observations from analysis of serial electrocardiographic and biochemical indicesE M Ohman, R Christenson, P Clemmensen, et al.
The American Journal of Cardiology|May 4, 2000
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trendsK R Campbell, E M Ohman, W Cantor, et al.
American Journal of Clinical Pathology|September 1, 1993
Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal functionR T Vollmer, R H Christenson, K Reimer, et al.
Journal of the Royal Society of Medicine|July 1, 1987
Adrenal suppression following low-dose topical clobetasol propionateE M Ohman, S Rogers, F O Meenan, et al.
Journal of Cardiovascular Pharmacology|December 1, 1987
Beta-adrenoceptor adaptation to endurance trainingE M Ohman, J Butler, J Kelly, et al.
Coronary Artery Disease|May 1, 1994
The role of angioplasty after successful thrombolysis for acute myocardial infarctionM Labinaz, S G Ellis, H R Phillips, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarctionM P Hudson, A B Greenbaum, R A Harrington, et al.
American Heart Journal|October 20, 1998
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findingsN S Kleiman, A M Lincoff, E M Ohman, et al.
Cardiovascular Toxicology|September 6, 2002
Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapiesR H Christenson, S H Duh, M T Roe, et al.
Clinical Chemistry|September 1, 1995
Biochemical markers in suspected acute myocardial infarction: the need for early assessmentL K Newby, W B Gibler, E M Ohman, et al.
Pageof 15